Addressing Racial and Ethnic Disparities in Kidney Disease
It has been more than a year and a half since the murder of George Floyd precipitated our on-going national discussion on racial inequity. This has been a difficult and at times polarizing conversation, but there is widespread recognition that addressing racial inequity is as urgent as ever. Differences in health, access to health care and life expectancy provide some of the most blatant measures of racial inequity. We, as health care providers, need to continue to confront the contribution of poor health care to persistent inequality and work to remedy it. We must also recognize the adverse societal conditions that lead to inequalities of health and be willing to lend our efforts to eliminate them. These conditions have been heightened in the COVID pandemic, but they are not new. What is new is increased recognition of the broad contribution of structural racism and amplified by attention to the consequent failure of our health care system to deliver optimum care to people of color. The AMA guidelines on structural racism represent an important step.